Arrowhead Pharmaceuticals, Inc.

NASDAQ:ARWR

21.51 (USD) • At close November 12, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997
Omzet 240.735243.231138.28787.992168.79616.14231.4080.1580.3820.1750.290.1470.2960.623.7731.3031.2080.5950.5910.19600.0020.0090.0250.0370.060.077
Kosten van de omzet 12.49310.421000000000000000.724000000.0060.0020.0030.0340.037
Brutowinst 228.242232.81138.28787.992168.79616.14231.4080.1580.3820.1750.290.1470.2960.623.7731.3030.4840.5950.5910.19600.0020.0030.0230.0340.0270.04
Brutowinstmarge 0.9480.957111111111111110.40111100.9620.3240.9160.9230.440.517
Onderzoek- en ontwikkelingskosten 353.188297.307206.342128.87581.04952.96931.6941.45457.4123.1388.7065.3913.2781.1118.97512.14520.9318.5823.7930.7930.003000000
Algemene en administratieve kosten 92.549124.43180.98152.27626.55619.1132.02340.99834.71824.4211.69314.0965.237.99514.146,848.3324,389.2325,034.1722.6770.91500000.0560.0120.011
Verkoop- en marketingkosten 19.68200000000000000-6,824.581-4,372.145-5,021.9173.3161.25700000.0340.0380.078
Verkoop-, algemene en administratieve kosten 92.549124.43180.98152.27626.55619.1132.02340.99834.71824.4211.69314.0965.237.99514.1423.75117.08712.2555.9932.1720.0910.1440.1090.1320.090.0510.09
Overige kosten 1.5385.7982.07-0.58300.0071.3130.0570.4180.082-0.9989,405.33,027.0955,127.5969,872.95717,312.9217,652.6098,219.8893.3161.2570000000
Bedrijfskosten 445.737421.738287.323181.151107.60572.07968.40479.8596.35651.27923.57121.23610.1269.42223.50236.30638.43321.8369.9532.9650.0941.4180.1090.1320.090.0690.198
Bedrijfsresultaat -205.002-178.507-149.036-93.15961.191-55.936-36.996-81.743-95.974-53.276-24.589-21.089-9.83-8.802-19.729-35.003-37.949-21.241-9.363-2.769-0.094-1.416-0.106-0.109-0.056-0.042-0.159
Bedrijfsresultaat ratio -0.852-0.734-1.078-1.0590.363-3.465-1.178-516.271-251.241-304.436-84.713-143.586-33.195-14.195-5.229-26.859-31.414-35.671-15.851-14.1050-624.984-11.412-4.391-1.519-0.701-2.071
Totaal overige inkomsten en kosten netto 1.5385.7988.198.6086.9580.442.203-2.2943.306-8.262-8.324-1.0570.9591.4660.571-0.1150-0.6832.375-0.01200.0530.060.094-0.2070.032-0.696
Inkomen voor belasting -206.491-172.709-140.846-84.55168.148-54.448-34.378-81.721-91.938-58.72-31.703-22.111-8.785-7.336-19.158-35.117-37.949-21.924-6.988-2.496-0.094-0.246-0.186-0.138-0.368-0.011-0.855
Inkomen voor belasting ratio -0.858-0.71-1.019-0.9610.404-3.373-1.095-516.131-240.677-335.543-109.221-150.541-29.665-11.831-5.077-26.947-31.414-36.819-11.83-12.7160-108.653-19.955-5.529-9.959-0.174-11.157
Belastingkosten 2.7843.7850.0020.0020.1740.0020.0020.0020.0020.0056.223-0.203-6.865-3.2480.054-8.028-8.018-2.243-2.7380.0010.001-1.170.080.028-0.6490.0090.696
Nettowinst -205.275-176.494-140.848-84.55367.975-54.45-34.38-81.723-91.941-58.63-31.143-21.126-3.129-5.774-19.308-27.089-29.931-18.997-6.625-2.497-0.095-0.246-0.186-0.1380.593-0.052-0.855
Nettowinstmarge -0.853-0.726-1.019-0.9610.403-3.373-1.095-516.146-240.683-335.03-107.292-143.836-10.566-9.312-5.117-20.787-24.777-31.904-11.216-12.720-108.653-19.955-5.52916.028-0.855-11.157
WPA (Winst Per Aandeel) -1.92-1.67-1.36-0.840.72-0.65-0.47-1.34-1.6-1.25-1.3-1.9-0.44-0.9-4.27-6.91-8.35-5.95-2.61-1.88-0.25-32.47-25.97-19.4897.4-10.16-175.33
Verwaterde WPA -1.92-1.67-1.36-0.840.69-0.65-0.47-1.34-1.6-1.25-1.3-1.9-0.44-0.9-4.27-6.91-8.35-5.95-2.61-1.88-0.25-32.47-25.97-19.4897.4-10.16-175.33
EBITDA -188.165-178.507-140.769-87.21765.63-51.669-33.196-74.08-96.526-41.493-14.845-18.523-10.684-9.833-18.831-33.869-36.946-19.67-11.094-2.682-0.094-1.46-0.163-0.1950.158-0.0560.641
EBITDA ratio -0.782-0.734-1.018-0.9910.389-3.201-1.057-467.875-252.686-237.105-51.143-126.114-36.078-15.857-4.991-25.989-30.584-33.034-18.781-13.6630-644.19-17.505-7.8574.283-0.9238.37